RNS Number : 6977L
Dechra Pharmaceuticals PLC
28 December 2018
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i


1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Dechra Pharmaceuticals plc

1b. Please indicate if the issuer is a non-UK issuer  (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:   

3. Details of person subject to the notification obligationiv

Name

Aviva plc & its subsidiaries    

City and country of registered office (if applicable)

London, England

4. Full name of shareholder(s) (if different from 3.)v

Name

Registered Holder:

 


Available on Request

                                           1,409*


Chase (GA Group) Nominees Limited

 

1,770,440*

 


Chase Nominees Limited                                  

 

18,472*

 


HSBC Global Custody Nominee (UK) Limited 

729,173*


State Street Nominees Limited

21,426*


                     

            * denotes direct interest

City and country of registered office (if applicable)


5. Date on which the threshold was crossed or reachedvi:

21/12/2018

6. Date on which issuer notified (DD/MM/YYYY):

24/12/2018

7. Total positions of person(s) subject to the notification obligation


Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

102,500,359

Position of previous notification (if

applicable)


 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type of
shares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

Indirect

Direct

Indirect

Ordinary Shares


GB0009633180

2,540,920

Not Disclosable

 2.48%

Not Disclosable











SUBTOTAL 8. A


B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expiration
datex

Exercise/
Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

RIGHT TO RECALL LOANED SHARES

N/A

N/A

538,672*

 

* DIRECT INTEREST

0.52%








SUBTOTAL 8. B 1

538,672

0.52%

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expiration
datex

Exercise/
Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights
















SUBTOTAL 8.B.2




 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Aviva plc



3.00%

Aviva Group Holdings Limited



3.00%

Aviva Investors Holdings Limited



3.00%

Aviva Investors Global Services Limited



3.00%





Aviva plc



3.00%

Aviva Group Holdings Limited



3.00%

Friends Provident

International Limited




 

 

10. In case of proxy voting, please identify:

Name of the proxy holder

See Section 4

The number and % of voting rights held


The date until which the voting rights will be held


 

 

 

 

11. Additional informationxvi

This notification is prompted by a <3% to 3% change at Direct Interest Level (Box 8A and 8B)

 

Place of completion

Norwich, England

Date of completion

24 December 2018

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLDMMZZRRVGRZG